DERMAPHARM HLDG INH O.N./ DE000A2GS5D8 /
| 04/11/2024 21:14:02 | Chg. +0.15 | Volume | Bid21:14:02 | Ask21:14:02 | Market Capitalization | Dividend Y. | P/E Ratio |
|---|---|---|---|---|---|---|---|
| 31.00EUR | +0.49% | 3,093 Turnover: 95,574.45 |
30.95Bid Size: 110 | 31.00Ask Size: 100 | 1.64 bill.EUR | 2.89% | 26.29 |
Assets
| 2018 - in mill. EUR |
2019 - in mill. EUR |
2020 - in mill. EUR |
2021 - in mill. EUR |
2022 IFRS in mill. EUR |
|||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
| Property and Equipment | 80.9000 | 132.6000 | 199.6000 | 222.3000 | 225.7000 | ||||||
| Intangible Assets | 189.9000 | 293 | 297.3000 | 294.8000 | 305 | ||||||
| Long-Term Investments | - | - | - | - | - | ||||||
| Fixed Assets | - | - | - | - | 878.9000 | ||||||
| Inventories | 117 | 175.6000 | 205.7000 | 243.6000 | 255.7000 | ||||||
| Accounts Receivable | - | - | - | - | 96.7000 | ||||||
| Cash and Cash Equivalents | 212.5000 | 115 | 120.3000 | 161.4000 | 151 | ||||||
| Current Assets | 371.2000 | 352.9000 | 400.1000 | 519.2000 | 533.9000 | ||||||
| Total Assets | 704.6000 | 1,044.9000 | 1,224.4000 | 1,407 | 1,412.8000 | ||||||
Liabilities
| 2018 - in mill. EUR |
2019 - in mill. EUR |
2020 - in mill. EUR |
2021 - in mill. EUR |
2022 IFRS in mill. EUR |
|||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
| Accounts Payable | 28.2000 | 35.4000 | 50.4000 | 52.1000 | 56.1000 | ||||||
| Long-term debt | 236.1000 | 562 | 581.1000 | 574.7000 | 511.6000 | ||||||
| Liabilities to Banks | 307.7000 | 580.4000 | 607.1000 | 581.1000 | - | ||||||
| Provisions | 36.1000 | 49.1000 | 62.6000 | 103.6000 | 164.7000 | ||||||
| Liabilities | 448.5000 | 760.4000 | 899.8000 | 907.1000 | 880.4000 | ||||||
| Share Capital | 53.8400 | 53.8400 | 53.8400 | 53.8400 | - | ||||||
| Total Equity | 256.1000 | 284.5000 | 324.6000 | 499.8000 | 531.6000 | ||||||
| Minority Interests | 3.6000 | 5.8000 | 2.6000 | 2.5000 | .9000 | ||||||
| Total liabilities equity | 704.6000 | 1,044.9000 | 1,224.4000 | 1,407 | 1,412.8000 | ||||||
Income Statement
| 2018 - in mill. EUR |
2019 - in mill. EUR |
2020 - in mill. EUR |
2021 - in mill. EUR |
2022 IFRS in mill. EUR |
|||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenues | 572.4000 | 701 | 793.8000 | 942.9000 | 1,024.8000 | ||||||
| Depreciation (total) | 30.3000 | 50.1000 | 49.2000 | 55.6000 | 101.2000 | ||||||
| Operating Result | 107.5000 | 119.5000 | 136.9000 | 298.5000 | 243.7000 | ||||||
| Interest Income | -5.1000 | -8.4000 | -10 | -5.8000 | -13.8000 | ||||||
| Income Before Taxes | 104.2000 | 110.1000 | 125.3000 | 293 | - | ||||||
| Income Taxes | 29 | 32.3000 | 39.4000 | 84.1000 | 134.2000 | ||||||
| Minority Interests Profit | 0.0000 | 0.0000 | 0.0000 | 0.0000 | -1.7000 | ||||||
| Net Income | 75.2000 | 77.8000 | 85.9000 | 208.9000 | 132.6000 | ||||||
Per Share
Cash Flow
| 2018 - in mill. EUR |
2019 - in mill. EUR |
2020 - in mill. EUR |
2021 - in mill. EUR |
2022 IFRS in mill. EUR |
|||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash Flow from Operating Activities | 159.1000 | 100.6000 | 131.1000 | 250.4000 | 288.5000 | ||||||
| Cash Flow from Investing Activities | -110 | -382.2000 | -105.9000 | -129.3000 | -99 | ||||||
| Cash Flow from Financing | 164.4000 | 184 | -14.1000 | -81 | -199.8000 | ||||||
| Decrease / Increase in Cash | 213.6000 | -97.6000 | 11.1000 | 40 | - | ||||||
| Employees | 1,619 | 1,853 | 2,311 | 2,373 | 2,563 | ||||||
